메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Nature Wood Group Limited Announces Change in Controlling Shareholder Following Completion of Private Share Transfer

MACAU, Oct. 23, 2025 -- Nature Wood Group Limited (Nasdaq: NWGL) ("Nature Wood" or the "Company"), a global leading vertically-integrated forestry company headquartered in Macau, today announced a change in its controlling shareholder following the closing of a private transaction. On October 22, 2025, the board of directors of the Company was notified that Mr. SE Hok Pan, Easy Bliss Limited, Linking Stars Limited, More Choice Global Limited, Mr. CHAN Wing Luk and Mr. HUANG Qing Cai (collectively, the "Sellers") completed the transfer of an aggregate of 11
- 황정호 기자
- 2025-10-23 02:31
Charming Medical Limited Announces Closing of Initial Public Offering

HONG KONG, Oct. 23, 2025 -- Charming Medical Limited (Nasdaq: MCTA) (the "Company"), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, today announced the closing of its initial public offering (the "Offering") of 1,600,000 Class A ordinary shares, par value $0.0001 per share (the "Class A Ordinary Shares") at a price of $4.00 per share (the "Public Offering Price"). The Company's Class A Ordinary Shares began trading on the Nasdaq Capital Market under the symbol "MCTA" on October 21, 2025.
- 황정호 기자
- 2025-10-23 00:51
SynbioTech Brings Taiwan's Biotech Excellence to the Global Stage with TWK10® for Muscle Performance and Healthy Aging

LAS VEGAS, Oct. 23, 2025 -- In a field where scientific validation defines credibility, Synbio Tech Inc., a biotechnology company from Taiwan, is gaining international recognition with its proprietary probiotic Lactiplantibacillus plantarum TWK10®. The clinically proven strain, which will be featured at SupplySide Global 2025 from October 27–30 (Booth #6253F), has shown measurable benefits on muscle strength, endurance, and balance—offering a new microbiome-based approach to healthy aging and active living. Backed by over a decade of research, TWK10® has been evaluated
- 김갑성 기자
- 2025-10-23 00:00
Largest Milestone Payment Secured: Biokin, a Rising Chinese Pharmaceutical MNC

BEIJING, Oct. 22, 2025 -- In October 2025, a partnership between Biokin—a rising star in China's innovative pharmaceutical sector—and global pharmaceutical leader BMS triggered a $250 million milestone payment. This is believed to be the largest antibody-drug conjugate (ADC) milestone payment among hundreds of out-licensing deals involving Chinese innovative drugs. Notably, the overall transaction had previously set a record for the total value of a single-drug asset license in China. In recent years, China's dynamic pharmaceutical ecosystem has rapidly emerged as one of the wo
- 김갑성 기자
- 2025-10-22 23:39
The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies

— Second U.S. site to deploy the Reveos™ system, boosting platelet supply and reducing waste LAKEWOOD, Colo., Oct. 22, 2025 -- To help address platelet shortages and streamline blood center operations, The Blood Center in New Orleans has become the second U.S. blood center to implement the Reveos™ Automated Blood Processing System and the Lumia™ Software Platform from Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company and global leader in blood management solutions. The move marks a significant step forward in transforming how blood centers process bl
- 김갑성 기자
- 2025-10-22 22:39
Invitation to Electrolux Group Capital Markets Update, December 4, 2025

STOCKHOLM, Oct. 22, 2025 -- Electrolux Group has the pleasure of inviting investors, financial analysts and business media representatives to its Capital Markets Update on December 4, 2025. The Capital Markets Update (CMU) will be held at Electrolux Group headquarters on S:t Göransgatan 143 in Stockholm, Sweden, starting at 14.00 CET on December 4, 2025, with registration from 13.30 CET. A live webcast will also be available. The agenda will include presentations by Yannick Fierling, President and CEO, and members of the Group Management team between 14.00 CET and approx. 1
- 황정호 기자
- 2025-10-22 22:36
CathWorks Announces Key Events for TCT 2025

The CathWorks FFRangio® System to be Center Stage, Featured in Multiple Scientific Sessions, Live Cases and a Primetime Academic Satellite Program NEWPORT BEACH, Calif., Oct. 22, 2025 -- CathWorks, a global leader in digital health innovations, announced today the schedule of key events for the company during the upcoming Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics (TCT) conference taking place October 25 to 28 at the Moscone Center in San Francisco, California. The CathWorks FFRangio® System will be featured in multiple
- 김갑성 기자
- 2025-10-22 22:05
ROLLER Secures US$50 Million to Invest in Next-Generation Technology for Leisure and Attractions Venues

Investment will accelerate AI innovation, expand financial services suite, strengthen existing offerings, and grow its ecosystem AUSTIN, Texas, Oct. 22, 2025 -- ROLLER, the all-in-one venue management platform for leisure and attractions venues, today announced it has secured an additional US$50 million to accelerate its next-generation solutions for its customers. The round was led by existing investor Insight Partners, who also led the company's US$50 million round in November 2023, with participation from J.P. Morgan, joining as a new funding provider. With this inves
- 황정호 기자
- 2025-10-22 22:00
Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity

TORONTO, Oct. 22, 2025 -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced the signing of a strategic cooperation agreement with Jiangsu Yike Regenerative Medical Technology Co., Ltd. ("Yike") to jointly establish Visionary Yike Stemcell Technologies Inc., a Canada-based joint venture dedicated to advancing stem cell research, clinical application, and commercialization worldwide. Under the agreement, GV and Yike will leverage their respective strengths in global co
- 황정호 기자
- 2025-10-22 21:30
NYSE Content Advisory: Pre-Market Update + Uniphore raises $260 million to boost AI leadership

NEW YORK, Oct. 22, 2025 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + Uniphore raises $260 million to boost AI leadership Ashley Mastronardi delivers the pre-market update on October 22nd Stocks are down Wednesday morning after the DOW closed at a record yesterday thanks to strong earnings from NYSE-listed firms Coca-Cola and 3M. The stocks jumped more than 4% and 7%, r
- 황정호 기자
- 2025-10-22 20:55

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-10-26_SUN

2025-10-25_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 26일 13시 40분